"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
Descriptor ID |
D000900
|
MeSH Number(s) |
D27.505.954.122.085
|
Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 2 | 0 | 2 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 3 | 0 | 3 |
2000 | 2 | 2 | 4 |
2001 | 0 | 2 | 2 |
2002 | 2 | 0 | 2 |
2003 | 1 | 1 | 2 |
2004 | 6 | 0 | 6 |
2005 | 3 | 1 | 4 |
2006 | 2 | 0 | 2 |
2007 | 4 | 1 | 5 |
2008 | 4 | 6 | 10 |
2009 | 4 | 2 | 6 |
2010 | 6 | 1 | 7 |
2011 | 4 | 6 | 10 |
2012 | 12 | 1 | 13 |
2013 | 4 | 1 | 5 |
2014 | 1 | 2 | 3 |
2015 | 4 | 3 | 7 |
2016 | 9 | 7 | 16 |
2017 | 6 | 6 | 12 |
2018 | 8 | 4 | 12 |
2019 | 3 | 6 | 9 |
2020 | 4 | 8 | 12 |
2021 | 2 | 5 | 7 |
2022 | 2 | 8 | 10 |
2023 | 2 | 11 | 13 |
2024 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
The impact of colistin-based regimens on mortality compared to other antimicrobials in patients with carbapenem-resistant Enterobacterales bacteremia in South African hospitals: a cross-sectional study. BMC Infect Dis. 2024 Jun 05; 24(1):561.
-
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries. Nat Commun. 2024 May 10; 15(1):3947.
-
Distributions of candidate vaccine Targets, virulence Factors, and resistance features of invasive group B Streptococcus using Whole-Genome Sequencing: A Multicenter, population-based surveillance study. Vaccine. 2024 Jun 11; 42(16):3564-3571.
-
Policy brief: Optimising antimicrobial usage in paediatric inpatient hospital settings. S Afr Med J. 2024 Apr 18; 114(4):e1296.
-
Carriage of antimicrobial-resistant Enterobacterales among pregnant women and newborns in Amhara, Ethiopia. Int J Infect Dis. 2024 Jun; 143:107035.
-
Vaccine value profile for Klebsiella pneumoniae. Vaccine. 2024 Jul 25; 42(19S1):S125-S141.
-
Incidence, pathogens and antimicrobial resistance of blood and cerebrospinal fluid isolates from a tertiary neonatal unit in South Africa: A 10 year retrospective review. PLoS One. 2024; 19(1):e0297371.
-
Child deaths caused by Klebsiella pneumoniae in sub-Saharan Africa and south Asia: a secondary analysis of Child Health and Mortality Prevention Surveillance (CHAMPS) data. Lancet Microbe. 2024 02; 5(2):e131-e141.
-
Structure-based identification of novel inhibitors targeting the enoyl-ACP reductase enzyme of Acinetobacter baumannii. Sci Rep. 2023 12 04; 13(1):21331.
-
Bacterial and Candida Colonization of Neonates in a Regional Hospital in South Africa. Pediatr Infect Dis J. 2024 Mar 01; 43(3):263-270.